ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2204

Fragility Fractures in a Community Setting: Clinical Characteristics, Care Gaps, and Outcomes

Rachel Kneeland1, Keile Wahle 1, Ishwar Gill 1, Yangyang Liu 2 and Monika Starosta 3, 1Department of Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, IL, 2Russell Center for Research & Innovation, Advocate Lutheran General Hospital, Park Ridge, IL, 3Department of Rheumatology, Advocate Lutheran General Hospital, Park Ridge, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: dual energy x-ray absorptiometry (DEXA) and treatment, fractures, osteoporosis, Recurrent fracture

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis-related fragility fractures contribute to significant morbidity and mortality. The risk of subsequent hip fracture is significantly increased after initial fracture, with some reports suggesting rates of recurrent fractures in hip and spine to be 41% and 45% at 1-year, respectively1. Hip fractures plateaued between 2002-2012, yet increased between 2013-2015 resulting in an estimated 11,000 additional fractures2. Despite widely available access to Dual-energy X-ray absorptiometry (DEXA) and treatment, this effect may be due to low rates of screening and treatment3. The purpose of this study was to identify the most common initial and secondary fractures, associated mortality, and frequency of screening and treatment.  

Methods: Adults aged 65 and older diagnosed with fragility fracture at Lutheran General Hospital from January 2012 to January 2017 were included in this analysis. Fragility fractures, defined as wrist, humerus, vertebral, hip, and pelvis, were identified with ICD9/ICD10 codes, along with demographic and clinical characteristics from the Advocate Health Care EMR system. Univariate analysis for continuous and categorical variables were conducted. Logistic regression was applied to examine the association of demographic characteristics and risk of fragility fractures. A two-tailed P level of .05 was considered statistically significant in all analyses. All analyses were performed using SAS 9.4.

Results: A total of 1,424 initial and 137 secondary fragility fractures were identified. For initial fractures, vertebral was most common (607, 42.63%), closely followed by hip (592, 41.92%), and pelvis (153, 12.08%). The majority of initial fracture patients were females (1021, 71.7%), Caucasians (1209, 84.9%) and the mean age was 82.1-years-old (range: 66-105). DEXA and treatment with anti-resorptive medications were recorded at time of initial fracture among 17.6% and 1.9% of patients, respectively. DEXA and treatment for patients with recurrent fractures were recorded among 27% and 31% of patients, respectively. There were no statistically significant differences for in-hospital all-cause mortality among vertebral, hip, and pelvic fractures.

Conclusion: Vertebral, hip, and pelvic fractures are a common cause of initial fragility fracture in those over age 65. Pelvic fractures may represent an under-reported cause of initial fragility fracture with similar rates of morbidity compared to hip and vertebral fractures. Rates of screening and treatment are low after initial and recurrent fractures. Future studies aimed investigating barriers to primary and secondary fracture prevention and treatment are warranted.

References: 

  1. Kanis JA, Johansson H, Oden A, Harvey NC, Gudnason V, Sanders KM, et al. Characteristics of recurrent fractures. Osteoporosis Int 2018; 29(8): 1747-1757.

  1. Lewiecki EM, Wright NC, Curtis JR, Siris E, Gagel RF, Saag KG, et al. Hip fracture trends in the United States, 2002 to 2015. Osteoporosis Int 2018; 29(3):717-722.

  1. Nguyen ET, Posas-Mendoza T, Siu AM, Ahn HJ, Choy SY, Lim Sy. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii. Osteoporosis Int 2018; 29(8):1827-1382.

Table 1. Demographic characteristics of top three most common initial fracture types. Abbreviations: % = percentage of patients within a particular fracture type for male and female and for all initial fractures -vertical summation- or percentage of patients within a particular race/ethnic group who sustained particular fracture types -horizontal summation-, SD = standard deviation.

Table 2. Distribution of in hospital all-cause mortality death or referral to hospice among fracture types and mean number of days hospitalized -SD = standard deviation- among patients with the top three most common initial fractures.


Disclosure: R. Kneeland, None; K. Wahle, None; I. Gill, None; Y. Liu, None; M. Starosta, None.

To cite this abstract in AMA style:

Kneeland R, Wahle K, Gill I, Liu Y, Starosta M. Fragility Fractures in a Community Setting: Clinical Characteristics, Care Gaps, and Outcomes [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/fragility-fractures-in-a-community-setting-clinical-characteristics-care-gaps-and-outcomes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fragility-fractures-in-a-community-setting-clinical-characteristics-care-gaps-and-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology